Cantor Fitzgerald Assumes Cidara Therapeutics (CDTX) at Overweight
Tweet Send to a Friend
(Updated - January 27, 2025 8:47 AM EST)
Cantor Fitzgerald analyst Eric Schmidt assumes coverage on Cidara Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Eric Schmidt assumes coverage on Cidara Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
